Blackrock Capital Allocation Term Trust Form 4 insider transactions

NYSE
Saba Capital Management, a 10% owner and director, disposed of 42,294 shares of BlackRock Capital Allocation Term Trust at a price of $15.59 on February 5, 2025.
NYSE
Saba Capital Management, a 10% owner of BlackRock Capital Allocation Term Trust (BCAT), has reported selling shares of common stock on February 3rd and 4th, 2025.
NYSE
Portfolio Manager Russell Jared Koesterich reports acquisition and disposal of common stock and phantom shares in BlackRock Capital Allocation Term Trust (BCAT) on January 31, 2025.
NYSE
Portfolio Manager Randy William Berkowitz reports transactions involving phantom shares of BlackRock Capital Allocation Term Trust, including acquisition and disposal, on January 31, 2025.
NYSE
Sarah Croughan Thompson, a Portfolio Manager at BlackRock Capital Allocation Term Trust, acquired phantom shares of common stock on January 31, 2025.
NYSE
Saba Capital Management, along with Boaz Weinstein, reported a decrease in their holdings of BlackRock Capital Allocation Term Trust shares through transactions on January 30th and 31st, 2025.
NYSE
Saba Capital Management, L.P. sold 945 shares of BlackRock Capital Allocation Term Trust at $15.54 per share on January 29, 2025, reducing their holdings to 13,604,745 shares.
NYSE
Saba Capital Management sold 6,383 shares of BlackRock Capital Allocation Term Trust, reducing their holdings to 13,605,690 shares.
NYSE
Saba Capital Management, a 10% owner of BlackRock Capital Allocation Term Trust, sold 5,204 shares of common stock at $15.76 per share on January 22, 2025.
NYSE
Saba Capital Management, a significant shareholder, sold 89,777 shares of BlackRock Capital Allocation Term Trust at $15.82 per share on December 26, 2024.
NYSE
Saba Capital Management sold 20,672 shares of BlackRock Capital Allocation Term Trust, reducing their holdings to 13,707,054 shares.
NYSE
Saba Capital Management, L.P. has decreased its holdings in BlackRock Capital Allocation Term Trust (BCAT) through recent sales of common stock.
NYSE
Saba Capital Management, a significant shareholder in BlackRock Capital Allocation Term Trust, has sold 5,120 shares of common stock at a price of $16.31 per share.
NYSE
Saba Capital Management, L.P. has decreased its holdings in BlackRock Capital Allocation Term Trust (BCAT) through recent sales of common stock.
NYSE
Saba Capital Management, a significant shareholder in BlackRock Capital Allocation Term Trust, has sold 154,418 shares of common stock at a price of $16.32 per share.
NYSE
Saba Capital Management, a significant shareholder, has decreased its holdings in BlackRock Capital Allocation Term Trust through recent transactions.
NYSE
Saba Capital Management sold 16,816 shares of BlackRock Capital Allocation Term Trust at $16.20 per share, reducing their holdings to 14,239,283 shares.
NYSE
Saba Capital Management, a significant shareholder, has sold 5,219 shares of BlackRock Capital Allocation Term Trust at a price of $16.13 per share.
NYSE
Saba Capital Management, L.P. has decreased its holdings in BlackRock Capital Allocation Term Trust through recent sales of common stock.
NYSE
Saba Capital Management, a significant shareholder, has sold 28,442 shares of BlackRock Capital Allocation Term Trust at a price of $16.07 per share.
NYSE
Saba Capital Management, L.P. has decreased its holdings in BlackRock Capital Allocation Term Trust (BCAT) through recent sales of common stock.
NYSE
Saba Capital Management, a significant shareholder, has sold a portion of its holdings in BlackRock Capital Allocation Term Trust.
NYSE
Saba Capital Management, a 10% owner of BlackRock Capital Allocation Term Trust, has reported selling shares of common stock on November 8th and 11th, 2024.
NYSE
Saba Capital Management reports a sale of BlackRock Capital Allocation Term Trust shares, decreasing their beneficial ownership.
NYSE
Saba Capital Management, a 10% owner of BlackRock Capital Allocation Term Trust, sold 4,649 shares of common stock at $16.07 per share on November 4, 2024.
NYSE
Saba Capital Management, a 10% owner and director, decreased its holdings in BlackRock Capital Allocation Term Trust (BCAT) through recent transactions.
NYSE
Stayce D. Harris, a director of BlackRock Capital Allocation Term Trust, purchased 60 shares of common stock on October 28, 2024.
NYSE
Saba Capital Management, a 10% owner of BlackRock Capital Allocation Term Trust (BCAT), reported a disposition of 15,482 shares of common stock on October 25, 2024, resulting in a slightly reduced beneficial ownership.
NYSE
Saba Capital Management, a 10% owner of BlackRock Capital Allocation Term Trust (BCAT), has decreased its holdings through recent stock sales.
NYSE
Saba Capital Management, a 10% owner and director of BlackRock Capital Allocation Term Trust, disposed of 28,670 shares of common stock at a price of $16.27 per share on October 21, 2024.